Effect of oral adsorbent on the progression of diabetic nephropathy

Nephron

Volumn 76, Issue 4, 1997, Pages 489-490

  Okada, Kazuyoshi ^a   Shibahara, Hiroshi ^a   Takahashi, Susumu ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AST 120; CARBON; OXIDE; SORBENT;

ADSORPTION; ANIMAL; DIABETIC NEPHROPATHY; DISEASE COURSE; EXPERIMENTAL DIABETES MELLITUS; LETTER; MALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; HYPERGLYCEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA;

ADSORPTION; ANIMALS; CARBON; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; MALE; OXIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030610174     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190236     Document Type: Article

References (4)

1. Sanaka T, Sugino N, Tcraoka S, et al: Therapeutic effects of oral sorbent in undialyzed uremia, Am J Kidney Dis 1988:12:97-103.
2. Okada K, Takahashi S: Correction by oral adsorbent of abnormal digestive milieu in rats with chronic renal failure, Nephrol Dial Transplant 1995:10:671-676.
3. Foga A, Ichikawa I: Glomerular growth promoter: The common channel to glomerulosclerosis: Mitch WE, Stein JH (eds): The Progressive Nature of Renal Disease, New York, Churchill Livingstone, 1992. pp 23-54.
4. Motojima M, Nishijima F, Sakai T, el at: Role for ‘uremic toxin’ in the progressive loss of intact nephron in chronic renal failure, Kidney Int 1991:40:461-469.